Multiple long-range inputs evoke NMDA currents in prefrontal cortex fast-spiking interneurons

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Luke Joseph Bogart, Patricio O'Donnell

Abstract

Several aspects of schizophrenia can be mimicked acutely in healthy human volunteers via administration of NMDA glutamate receptor (NMDAR) antagonists. As these agents decrease firing rates in prefrontal cortical (PFC) GABAergic fast-spiking interneurons (FSI) in animal studies, a leading hypothesis on schizophrenia pathophysiology is that NMDAR in FSI are impaired. However, whole-cell recordings of FSI in slices of adult mouse PFC revealed limited amounts of NMDAR-mediated current. Since those studies used local electrical stimulation to activate a heterogeneous set of synaptic inputs to the recorded cell, it is unclear whether specific afferent inputs may preferentially drive NMDAR responses in FSI. Here, we expressed opsins in discrete brain regions projecting to the PFC in adult male mice, enabling light-activation of defined, homogenous sets of long-range inputs to FSI and pyramidal neurons recorded in slices containing medial PFC (mPFC). Stimulation of axons originating from either the contralateral mPFC, ventral hippocampus, or mediodorsal thalamus evoked NMDAR-mediated currents in the vast majority of FSI and in all pyramidal neurons recorded. The observation that multiple long-range inputs to mPFC FSI elicit NMDAR curr...Continue Reading

References

Oct 1, 1991·The American Journal of Psychiatry·D C Javitt, S R Zukin
Sep 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Mario Galarreta, Shaul Hestrin
Jul 6, 2004·The European Journal of Neuroscience·Patrick L TierneyYves Gioanni
Oct 29, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Bidisha ChattopadhyayaZ Josh Huang
Apr 6, 2005·Archives of General Psychiatry·Andreas S Meyer-LindenbergKaren Faith Berman
Nov 2, 2005·Nature Reviews. Neuroscience·Takao K Hensch
Jul 5, 2006·Cerebral Cortex·Kuei-Yuan Tseng, Patricio O'Donnell
Mar 6, 2007·Nature Neuroscience·Scott J CruikshankBarry W Connors
Oct 26, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Houman Homayoun, Bita Moghaddam
Jun 17, 2008·Nature Neuroscience·Stephen R Williams, Simon J Mitchell
Feb 27, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Huai-Xing Wang, Wen-Jun Gao
Jul 17, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Court HullMassimo Scanziani
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Anja NörenbergPeter Jonas
Dec 15, 2010·Developmental Neurobiology·Bernardo RudyJens Hjerling-Leffler
Jan 7, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Diana C RotaruGuillermo Gonzalez-Burgos
Dec 14, 2011·Trends in Neurosciences·David A LewisDavid W Volk
Jan 13, 2012·Journal of Neurophysiology·Nadezhda V Povysheva, Jon W Johnson
Jan 19, 2012·Nature Reviews. Neuroscience·Oscar Marín
Oct 4, 2012·The American Journal of Psychiatry·Neil D WoodwardStephan Heckers
Feb 11, 2014·Nature Methods·Nathan C KlapoetkeEdward S Boyden
May 30, 2014·Schizophrenia Bulletin·Peter Kochunov, L Elliot Hong
Mar 20, 2015·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nikolai C DembrowDaniel Johnston
Apr 10, 2015·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kristen DelevichBo Li

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection

Software Mentioned

ImageJ
GraphPad
Prism
MiniAnalysis
Clampfit
Clampex
Fiji

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here